The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Research Report 2024

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1424813

No of Pages : 98

Synopsis
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ 2363 million in 2023 and is anticipated to reach US$ 2107.8 million by 2030, witnessing a CAGR of -1.6% during the forecast period 2024-2030.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
This report aims to provide a comprehensive presentation of the global market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs.
Report Scope
The Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Others
Segment by Application
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
1.1 Product Overview and Scope of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type
1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value Comparison by Type (2024-2030)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application
1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Value by Application: (2024-2030)
1.3.2 Acute CINV
1.3.3 Delayed CINV
1.3.4 Breakthrough CINV
1.3.5 Others
1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2019-2030
1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2019-2030
1.4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competition by Manufacturers
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
2.7 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Situation and Trends
2.7.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue
2.7.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario by Region
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2019-2030
3.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2019-2024
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region: 2025-2030
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2019-2030
3.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2019-2024
3.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region: 2025-2030
3.4 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.4.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2019-2030)
3.4.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.5.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2019-2030)
3.5.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.7.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2019-2030)
3.7.3 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2019-2030)
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2019-2024)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2025-2030)
4.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2019-2030)
4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2019-2030)
4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2019-2024)
4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2025-2030)
4.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2019-2030)
5.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2019-2024)
5.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2025-2030)
5.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2019-2030)
5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2019-2030)
5.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2019-2024)
5.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2025-2030)
5.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Heron Therapeutics
6.1.1 Heron Therapeutics Corporation Information
6.1.2 Heron Therapeutics Description and Business Overview
6.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.1.5 Heron Therapeutics Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Corporation Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Mundipharma
6.4.1 Mundipharma Corporation Information
6.4.2 Mundipharma Description and Business Overview
6.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.4.5 Mundipharma Recent Developments/Updates
6.5 Qilu Pharma
6.5.1 Qilu Pharma Corporation Information
6.5.2 Qilu Pharma Description and Business Overview
6.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.5.5 Qilu Pharma Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 GSK
6.11.1 GSK Corporation Information
6.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.11.5 GSK Recent Developments/Updates
6.12 Helsinn
6.12.1 Helsinn Corporation Information
6.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.12.5 Helsinn Recent Developments/Updates
6.13 Southwest Pharma
6.13.1 Southwest Pharma Corporation Information
6.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.13.5 Southwest Pharma Recent Developments/Updates
6.14 Haisco
6.14.1 Haisco Corporation Information
6.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.14.5 Haisco Recent Developments/Updates
6.15 Sun Pharma
6.15.1 Sun Pharma Corporation Information
6.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.15.5 Sun Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Chain Analysis
7.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Mode & Process
7.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Marketing
7.4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Channels
7.4.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors
7.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
8 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Dynamics
8.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
8.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
8.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
8.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’